Chemed Corporation $CHE Stock Holdings Lifted by Lone Peak Global Investors LLC

Key Points

• Lone Peak Global Investors increased its Chemed stake by 38.1% in the second quarter, bringing its holdings to 37,099 shares valued at approximately $17.3 million. Institutional investors collectively own 95.85% of the company.
• Chemed exceeded quarterly expectations, reporting earnings of $6.06 per share versus the $5.60 consensus and revenue of $673.25 million, up 8.8% year over year.
• The company raised its quarterly dividend from $0.60 to $0.70 per share, while analysts maintained a consensus “Hold” rating with an average price target of $530.75.

Lone Peak Global Investors LLC grew its position in Chemed Corporation (NYSE:CHE - Free Report) by 38.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 37,099 shares of the company's stock after purchasing an additional 10,226 shares during the period. Chemed comprises about 2.4% of Lone Peak Global Investors LLC's holdings, making the stock its 25th largest position. Lone Peak Global Investors LLC owned approximately 0.28% of Chemed worth $17,279,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Monetary Solutions Ltd bought a new stake in shares of Chemed in the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed in the fourth quarter worth approximately $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed during the fourth quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Chemed during the second quarter valued at approximately $34,000. Finally, Versant Capital Management Inc lifted its stake in Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company's stock valued at $35,000 after acquiring an additional 75 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Down 0.5%

Shares of Chemed stock opened at $515.96 on Wednesday. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The stock has a 50 day moving average price of $512.52 and a two-hundred day moving average price of $450.53. The stock has a market capitalization of $6.74 billion, a P/E ratio of 25.91, a PEG ratio of 1.96 and a beta of 0.51.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company's quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the firm posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be paid a $0.70 dividend. The ex-dividend date is Monday, August 17th. This is a boost from Chemed's previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's dividend payout ratio is presently 14.06%.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the sale, the chief executive officer owned 70,418 shares in the company, valued at $37,991,215.18. This represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 6,537 shares of company stock worth $3,406,014 over the last quarter. 3.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

CHE has been the subject of several recent research reports. Bank of America reissued a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Oppenheimer lifted their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research note on Friday, July 31st. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th. Finally, Wall Street Zen raised shares of Chemed from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 1st. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Chemed currently has an average rating of "Hold" and a consensus target price of $530.75.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source